Publications
Recent + Selected
Recent Selected Publications
Cancer Population Sciences
Dhakal B, Patel S, Girnius S, Bachegowda L, Fraser R, Davila O, Kanate A, Assal A, Hanbali A, Bashey A, Pawarode A, Freytes C, Lee C, Vesole D, Cornell R, Hildebrandt G, Murthy H, Lazarus H, Cerny J, Yared J, Schriber J, Berdeja J, Stockerl-Goldstein K, Meehan K, Holmberg L, Solh M, Diaz MA, Kharfan-Dabaja MA, Farhadfar N, Bashir Q, Munker R, Olsson RF, Gale RP, Bayer RL, Seo S, Chhabra S, Hashmi S, Badawy SM, Nishihori T, Gonsalves W, Nieto Y, Efebera Y, Kumar S, Shah N, Qazilbash M, Hari P, D’Souza A (2020) Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era. Leukemia ():. PM ID: 32313109
Amdur R, Yeung A. (2020) Washing Away the Fear. Pract Radiat Oncol ():. PM ID: 32315782
Du X, Min J, Shah C, Bishnoi R, Hogan W, Lemas D. (2020) Predicting in-hospital mortality of patients with febrile neutropenia using machine learning models. Int J Med Inform 139():104140. PM ID: 32325370
Riner A, Underwood P, Yang K, Herremans K, Cameron M, Chamala S, Qiu P, George T, Permuth J, Merchant N, Trevino J. (2020) Disparities in Pancreatic Ductal Adenocarcinoma-The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes. Cancer Med ():. PM ID: 32285629
Golden S, Ono S, Thakurta S, Wiener R, Iaccarino J, Melzer A, Datta S, Slatore C. (2020) “I’m putting my trust in their hands”: A qualitative study of patients’ views on clinician initial communication about lung cancer screening. Chest ():. PM ID: 32278782
Su Z, Indelicato D, Mailhot R, Bradley J. (2020) Impact of different treatment techniques for pediatric Ewing sarcoma of the chest wall: IMRT, 3DCPT, and IMPT with/without beam aperture. J Appl Clin Med Phys ():. PM ID: 32268008
Forsmark C, Tang G, Xu H, Tuft M, Hughes S, Yadav D. (2020) The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent. Aliment. Pharmacol. Ther. ():. PM ID: 32249970
Xu Y, Scharfstein D, Müller P, Daniels M. (2020) A Bayesian nonparametric approach for evaluating the causal effect of treatment in randomized trials with semi-competing risks. Biostatistics ():. PM ID: 32247284
Indelicato D, Rotondo R, Krasin M, Mailhot Vega R, Uezono H, Bradfield S, Agarwal V, Morris C, Bradley J. (2020) Outcomes Following Proton Therapy for Group III Pelvic Rhabdomyosarcoma. Int. J. Radiat. Oncol. Biol. Phys. 106(5):968-976. PM ID: 31987977
Diaby V, Wang C, Alqhtani H, van Boemmel-Wegmann S, Ali A, Balkrishnan R, Ko Y, Palacio S, de Lima Lopes G. (2020) Dataset used in the economic evaluation trastuzumab-based regimens for HER-2 positive metastatic breast cancer patients in the Taiwanese healthcare setting. Data Brief 29():105194. PM ID: 32071975 PMC ID: PMC7011026
Yuan C, Xie Z, Bian J, Huo J, Daily K. (2020) Outcomes of primary endocrine therapy in elderly women with stage I-III breast cancer: a SEER database analysis. Breast Cancer Res. Treat. 180(3):819-827. PM ID: 32172303
Theis R, Wells B, Staras S. (2020) “I can be the Judge of What’s Serious”: A Qualitative Pilot Study of Parents’ Responses to Messaging About Side Effects of the HPV Vaccine. Matern Child Health J 24(4):456-461. PM ID: 31893386 PMC ID: PMC7082199
Principe D, Narbutis M, Kumar S, Park A, Viswakarma N, Dorman M, Kamath S, Grippo P, Fishel M, Hwang R, Thummuri D, Underwood P, Munshi H, Trevino J, Rana A. (2020) Long-Term Gemcitabine Treatment Reshapes the Pancreatic Tumor Microenvironment and Sensitizes Murine Carcinoma to Combination Immunotherapy. Cancer Res. ():. PM ID: 32238357
Cancer Therapeutics & Host Response
Qumseya B, Gendy S, Wallace A, Yang D, Estores D, Ayzengart A, Draganov P. (2020) Prevalence of Barrett’s esophagus in obese patients undergoing pre-bariatric surgery evaluation: a systematic review and meta-analysis. Endoscopy ():. PM ID: 32325514
Tamashunas A, Tocco V, Matthews J, Zhang Q, Atanasova K, Paschall L, Pathak S, Ratnayake R, Stephens A, Luesch H, Licht J, Lele T. (2020) High-throughput gene screen reveals modulators of nuclear shape. Mol. Biol. Cell ():mbcE19090520. PM ID: 32320319
Sokol E, Desai A, Applebaum M, Valteau-Couanet D, Park J, Pearson A, Schleiermacher G, Irwin M, Hogarty M, Naranjo A, Volchenboum S, Cohn S, London W. (2020) Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project. J. Clin. Oncol. ():JCO1903285. PM ID: 32315273
Amdur R, Yeung A. (2020) Washing Away the Fear. Pract Radiat Oncol ():. PM ID: 32315782
Zhang X, Thummuri D, Liu X, Hu W, Zhang P, Khan S, Yuan Y, Zhou D, Zheng G. (2020) Discovery of PROTAC BCL-XL degraders as potent anticancer agents with low on-target platelet toxicity. Eur J Med Chem 192():112186. PM ID: 32145645
Jaiswal M, Zhu S, Jiang W, Guo Z. (2020) Synthesis and evaluation of Nα,Nε-diacetyl-l-lysine-inositol conjugates as cancer-selective probes for metabolic engineering of GPIs and GPI-anchored proteins. Org. Biomol. Chem. 18(15):2938-2948. PM ID: 32242600
Liu N, Yang D, Draganov P. (2020) Endoscopic Stenting for Malignant Hilar Biliary Obstruction: After You Double Down, Are You In or Out? Dig. Dis. Sci. ():. PM ID: 32297066
Riner A, Underwood P, Yang K, Herremans K, Cameron M, Chamala S, Qiu P, George T, Permuth J, Merchant N, Trevino J. (2020) Disparities in Pancreatic Ductal Adenocarcinoma-The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes. Cancer Med ():. PM ID: 32285629
Bian T, Tagmounti A, Vulpe C, Vijendra K, Xing C. (2020) CXL146, a novel 4H-chromene derivative, targets GRP78 to selectively eliminate multidrug resistant cancer cells. Mol. Pharmacol. ():. PM ID: 32276963
Kowalski L, Sanabria A, Ridge J, Ng W, de Bree R, Rinaldo A, Takes R, Mäkitie A, Carvalho A, Bradford C, Paleri V, Hartl D, Vander Poorten V, Nixon I, Piazza C, Lacy P, Rodrigo J, Guntinas-Lichius O, Mendenhall W, D’Cruz A, Lee A, Ferlito A. (2020) COVID-19 pandemic: Effects and evidence-based recommendations for otolaryngology and head and neck surgery practice. Head Neck ():. PM ID: 32270581
Su Z, Indelicato D, Mailhot R, Bradley J. (2020) Impact of different treatment techniques for pediatric Ewing sarcoma of the chest wall: IMRT, 3DCPT, and IMPT with/without beam aperture. J Appl Clin Med Phys ():. PM ID: 32268008
Hill-Kayser C, Indelicato D, Ermoian R, Salerno K, Breneman J. (2020) Pediatric Central Nervous System Germinoma: What can we understand from a worldwide effort to maximize cure and minimize risk? Int. J. Radiat. Oncol. Biol. Phys. ():. PM ID: 32275995
Forsmark C, Tang G, Xu H, Tuft M, Hughes S, Yadav D. (2020) The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent. Aliment. Pharmacol. Ther. ():. PM ID: 32249970
Medikonda R, Dunn G, Rahman M, Fecci P, Lim M. (2020) A review of glioblastoma immunotherapy. J. Neurooncol. ():. PM ID: 32253714
Hoppe B, Nichols R, Flampouri S, Li Z, Morris C, Pham D, Mohindra P, Hartsell W, Mohammed N, Chon B, Simone C. (2020) Hypofractionated proton therapy with concurrent chemotherapy for locally advanced non-small cell lung cancer: A Phase I trial from the University of Florida and Proton Collaborative Group. Int. J. Radiat. Oncol. Biol. Phys. ():. PM ID: 32251754
Silver N, Weber R, Lozano M, Hessel A, Meade J, Moore J, Hanna E, Lewis C. (2020) Reducing patient wait times in a head and neck cancer outpatient clinic: A pilot study. Laryngoscope 130(4):E151-E154. PM ID: 31070242
Indelicato D, Rotondo R, Krasin M, Mailhot Vega R, Uezono H, Bradfield S, Agarwal V, Morris C, Bradley J. (2020) Outcomes Following Proton Therapy for Group III Pelvic Rhabdomyosarcoma. Int. J. Radiat. Oncol. Biol. Phys. 106(5):968-976. PM ID: 31987977
Braswell D, Ayoubi N, Motaparthi K, Walker A. (2020) Dermatofibrosarcoma protuberans with features of giant cell fibroblastoma in an adult. J. Cutan. Pathol. 47(4):317-320. PM ID: 32163628
Yuan C, Xie Z, Bian J, Huo J, Daily K. (2020) Outcomes of primary endocrine therapy in elderly women with stage I-III breast cancer: a SEER database analysis. Breast Cancer Res. Treat. 180(3):819-827. PM ID: 32172303
Dziegielewski P, McNeely M, Ashworth N, O’Connell D, Barber B, Courneya K, Debenham B, Seikaly H. (2020) 2b or not 2b? Shoulder function after level 2b neck dissection: A double-blind randomized controlled clinical trial. Cancer 126(7):1492-1501. PM ID: 31873950
Zhou J, Sun X, Yang L, Wang L, Ran G, Wang J, Cao Q, Wu L, Bryant A, Ling C, Pi L. (2020) Hepatocyte nuclear factor 4α negatively regulates connective tissue growth factor during liver regeneration. FASEB J. 34(4):4970-4983. PM ID: 32057145
Kissoon T, Godder K, Fort J. (2020) Infusion of Hematopoietic Stem Cell Products Using Pump Mechanism: An Approach Worth Consideration? J. Pediatr. Hematol. Oncol. 42(3):e174-e176. PM ID: 31033784
Hlubocky F, Taylor L, Marron J, Spence R, McGinnis M, Brown R, McFarland D, Tetzlaff E, Gallagher C, Rosenberg A, Popp B, Dragnev K, Bosserman L, Dudzinski D, Smith S, Chatwal M, Patel M, Markham M, Levit K, Bruera E, Epstein R, Brown M, Back A, Shanafelt T, Kamal A. (2020) A Call to Action: Ethics Committee Roundtable Recommendations for Addressing Burnout and Moral Distress in Oncology. JCO Oncol Pract 16(4):191-199. PM ID: 32223701
Cogle C, Collins B, Turner D, Pettiford L, Bossé R, Hawkins K, Beachamp Z, Wise E, Cline C, May W, Moreb J, Hsu J, Hiemenz J, Brown R, Norkin M, Wingard J, Uckun F. (2020) Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes. Br. J. Haematol. ():. PM ID: 32236943
Ratnayake R, Gunasekera S, Ma J, Dang L, Carney T, Paul V, Luesch H. (2020) Dolastatin 15 from a Marine Cyanobacterium Suppresses HIF-1α Mediated Cancer Cell Viability and Vascularization. Chembiochem ():. PM ID: 32237262
Mechanisms of Oncogenesis
Tamashunas A, Tocco V, Matthews J, Zhang Q, Atanasova K, Paschall L, Pathak S, Ratnayake R, Stephens A, Luesch H, Licht J, Lele T. (2020) High-throughput gene screen reveals modulators of nuclear shape. Mol. Biol. Cell ():mbcE19090520. PM ID: 32320319
Emmanuel S, Mietzsch M, Tseng Y, Smith J, Agbandje-McKenna M. (2020) Parvovirus Capsid-Antibody Complex Structures Reveal Conservation of Antigenic Epitopes Across the Family. Viral Immunol. ():. PM ID: 32315582
Çağlayan M. (2020) The ligation of pol β mismatch insertion products governs the formation of promutagenic base excision DNA repair intermediates. Nucleic Acids Res. 48(7):3708-3721. PM ID: 32140717 PMC ID: PMC7144901
Zhang X, Thummuri D, Liu X, Hu W, Zhang P, Khan S, Yuan Y, Zhou D, Zheng G. (2020) Discovery of PROTAC BCL-XL degraders as potent anticancer agents with low on-target platelet toxicity. Eur J Med Chem 192():112186. PM ID: 32145645
Cheong C, Mrozik K, Hewett D, Bell E, Panagopoulos V, Noll J, Licht J, Gronthos S, Zannettino A, Vandyke K. (2020) Twist-1 is upregulated by NSD2 and contributes to tumour dissemination and an epithelial-mesenchymal transition-like gene expression signature in t(4;14)-positive multiple myeloma. Cancer Lett. 475():99-108. PM ID: 32014459
Pan L, Chen X, Fu S, Yu W, Li C, Wang T, Lo H, Lin J. (2020) LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer. Breast Cancer Res. Treat. ():. PM ID: 32240456
Zhao C, Yang L, Zhou F, Yu Y, Du X, Xiang Y, Li C, Huang X, Xie C, Liu Z, Lin J, Wang L, Liang G, Cui R. (2020) Feedback activation of EGFR is the main cause for STAT3 inhibition-irresponsiveness in pancreatic cancer cells. Oncogene ():. PM ID: 32242147
Zhou J, Sun X, Yang L, Wang L, Ran G, Wang J, Cao Q, Wu L, Bryant A, Ling C, Pi L. (2020) Hepatocyte nuclear factor 4α negatively regulates connective tissue growth factor during liver regeneration. FASEB J. 34(4):4970-4983. PM ID: 32057145